Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer.

Yukinori OkadaMariko KobayashiMio ShinozakiTatsuyuki AbeYoshihide KanemakiNaoki NakamuraYasuyuki Kojima

Published in: Acta radiologica open (2020)

HER2-type and 37.5 Gy/15 fractions are good prognostic factor after whole-brain radiotherapy in breast cancer with brain metastases.

Keyphrases